The incidence and mortality from lung cancer is decreasing in the US due to decades of
public education and tobacco control policies, but are increasing elsewhere in the world …

The history of lung cancer epidemiology parallels the history of modern chronic disease
epidemiology. Although an excess of lung cancer was firstly observed among miners and …

To explore the biology of lung adenocarcinoma (LUAD) and identify new therapeutic
opportunities, we performed comprehensive proteogenomic characterization of 110 tumors …

Lung cancer remains a significant health problem worldwide for both men and women and
is the leading cause of cancer death in many countries. Age-adjusted lung cancer incidence …

Advancements in the development of computer-aided decision (CAD) systems for clinical
routines provide unquestionable benefits in connecting human medical expertise with …

Non-small cell lung cancer (NSCLC) in non-, and especially in never-smoking patients is
considered a biologically unique type of lung cancer, since risk factors and tumorigenic …

Lung cancer is a leading cause of global cancer deaths. Na/K-ATPase has been studied as
a target for cancer treatment. Cardiotonic steroids (CS) trigger intracellular signalling upon …

Continued decrease in smoking prevalence and increasing use of sensitive diagnostic
procedures necessitate updated monitoring of trends in lung cancer incidence in Japan. We …

Background Non-small-cell lung cancer (NSCLC) is the most common type of lung cancer.
NSCLC accounts for 84% of all lung cancer cases. In recent years, advances in pathway …

Introduction Women represent a higher proportion than men among those with lung cancer
in nonsmokers compared to smokers. The reason for this abnormally higher proportion is not …